
Eldopoz MF 15mg/500mg Tablet
Marketer
El-Dorado Bio-Tech Pvt Ltd
Salt Composition
Pioglitazone (15mg) + Metformin (500mg)
Overview Eldopoz MF 15mg/500mg Tablet
Metformin and Pioglitazone 15mg/500mg tablets offer combined blood glucose management. This medication, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, resulting in lower blood sugar. Dosage and frequency should strictly follow your physician's instructions. Take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Common, generally mild, side effects may include nausea, appetite loss, altered taste, abdominal pain, diarrhea, and swelling. Persistent or concerning side effects warrant medical attention. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or nursing individuals should also seek medical counsel. Kidney function will be assessed before prescription. Limit alcohol consumption, as it may heighten the risk of adverse reactions.
Primary Ingredients of Eldopoz MF 15mg/500mg Tablet
No text provided to rephrase.
Uses of Eldopoz MF 15mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Eldopoz MF 15mg/500mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Eldopoz MF 15mg/500mg tablet whole; do not break, crush, or chew it. Administer this medication with food.
Common Side effects of Eldopoz MF 15mg/500mg Tablet:
- Diarrhea
- Edema (swelling)
- Headache
- Nausea
- Vomiting
- Hypoglycemia (low blood glucose level)
- Dizziness
- Urinary tract infection
- Upper respiratory tract infection
- Sinus infection
How to use Eldopoz MF 15mg/500mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Eldopoz MF 15mg/500mg tablets with food.
How Eldopoz MF 15mg/500mg Tablet works:
Each Eldopoz MF 15mg/500mg tablet contains a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Eldopoz MF 15mg/500mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Eldopoz MF 15mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Eldopoz MF 15mg/500mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Eldopoz MF 15mg/500mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. The medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
For individuals with liver impairment, the use of Eldopoz MF 15mg/500mg tablets requires careful monitoring. Dosage modifications may be necessary. Medical advice is essential. A reduced initial dose is typically prescribed for patients exhibiting mild to moderate liver disease; however, its administration is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Eldopoz MF 15mg/500mg Tablet :
Should you forget to take your Eldopoz MF 15mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eldopoz MF 15mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
